# Utility of a Novel Dd-cfDNA Test to Detect Injury in Renal Post-Transplant Patients

> **NCT03765203** · NA · COMPLETED · sponsor: **Qure Healthcare, LLC** · enrollment: 175 (actual)

## Conditions studied

- Transplant;Failure,Kidney

## Interventions

- **DIAGNOSTIC_TEST:** Natera KidneyScan
- **OTHER:** Clinical Performance and Value Vignettes

## Key facts

- **NCT ID:** NCT03765203
- **Lead sponsor:** Qure Healthcare, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-11-05
- **Primary completion:** 2019-01-07
- **Final completion:** 2019-01-07
- **Target enrollment:** 175 (ACTUAL)
- **Last updated:** 2020-09-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03765203

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03765203, "Utility of a Novel Dd-cfDNA Test to Detect Injury in Renal Post-Transplant Patients". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT03765203. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*